Health Condition 1: K219- Gastro-esophageal reflux disease without esophagitis
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1 patient presenting with laxanas of Amlapitta 2 patient who is willing to participate in clinical trial with full cooperation
Exclusion criteria
Exclusion criteria: 1 pregnant and lactating women 2 patient suffering with Gastric ulcer peptic ulcer hypertension diabetes cardiac related disorders 3 subjects having history of more than 1 year
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in Burning sensation in throat regionTimepoint: Assessments will be done at Baseline Day 0, after completion of treatment Day 15, at first follow up on Day 30, second follow up on day 45 | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement in symptoms such as indigestion, nausea, sour/bitter belching & loss of appetiteTimepoint: Assesement will be done at baseline Day 0, after completion of treatment Day 15, at first follow up on Day 30 & at 2nd follow up on Day 45 | — |
Countries
India
Contacts
SHRI VIJAYA MAHANTESH AYURVEDIC MEDICAL COLLEGE ILKAL BAGALKOTE KARNATAKA